Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations

Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations

Xiang Han,1 Yunhong You,1 Xiuhui Guo,2 Youxin Ji,1 Keke Nie1 1Department of Oncology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), Qingdao, 266042, People’s Republic of China; 2Department of Oncology, Pingdu People’s Hospital, Qingdao, 266077...

Full description

Saved in:
Bibliographic Details
Main Authors: Han X, You Y, Guo X, Ji Y, Nie K
Format: Article
Language:English
Published: Dove Medical Press 2024-11-01
Series:International Journal of General Medicine
Subjects:
epidermal growth factor receptor tyrosine kinase inhibitor
uncommon egfr mutations
non-small-cell lung cancer
afatinib
bevacizumab
Online Access:https://www.dovepress.com/afatinib-combined-with-bevacizumab-in-the-treatment-of-patients-with-n-peer-reviewed-fulltext-article-IJGM
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/afatinib-combined-with-bevacizumab-in-the-treatment-of-patients-with-n-peer-reviewed-fulltext-article-IJGM

Similar Items